Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study.
Explore this paper's citation graph
Summary
It is shown that plasma fibrinogen concentrations may be a useful marker for identifying individuals at high risk of developing arterial thrombotic disorders and was somewhat stronger in cigarette smokers than in nonsmokers.
- Type
- article
- Published
- 1992-07-01
- Cited by
- 70
- References
- 24
- OpenAlex
- https://openalex.org/W1981655129
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:22045914
Keywords
Medicine, Fibrinogen, Von Willebrand factor, Antithrombin, Internal medicine
References
- ARICHemostasis Study - I. Development of a Blood Collection and Processing System Suitable for Multicenter Hemostatic Studies
- Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
- Letter: Discharge of violent patients.
- Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland.
- Noninvasive assessment of atherosclerosis.
- Fibrinogen and risk of cardiovascular disease. The Framingham Study.
- Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk.
- Natural anticoagulant mechanisms.
- Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.
- Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
- The regulation of natural anticoagulant pathways
- Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study.
- Plasma fibrinogen--a major coronary risk factor.
- Fibrinogen and fibrin.
- Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency.
- Regression models in clinical studies: determining relationships between predictors and response.
- Discrete Multivariate Analysis.
- Fibrinogen as a risk factor for stroke and myocardial infarction.
- Sources of Variability in Coagulation Factor Assays
- The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.
Cited by
- Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.
- Haemostasis and cardiovascular disease
- Fibrinogen and Cardiovascular Risk
- Correlates of Antithrombin, Protein C, Protein S, and TFPI in a Healthy Elderly Cohort
- Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
- Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
- Thrombophilia in patients with hypercholesterolemia.
- Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
- Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects.
- Recent advances in hemostatic risk factors and cardiovascular diseases
- Lack of Very Strong Association between Pre-Treatment Fibrinogen and PAI-1 with Long-Term Mortality after Coronary Bypass Surgery
- B-mode ultrasound-detected carotid artery lesions with and without acoustic shadowing and their association with markers of inflammation and endothelial activation: the atherosclerosis risk in communities study.
- An Association between Clotting Factor VII and Carotid Intima-Media Thickness: The CARDIA Study
- Plasma fibrinogen and wall thickness in carotid and femoral arteries: findings from the KIHD study
- Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study.
- Contribution of factor VII, fibrinogen and fibrinolytic components to the risk of ischaemic cardiovascular disease: their genetic determinants
- Assessment of coronary heart disease risk by combined analysis of coagulation factors.
- Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease.
- Imaging Biomarkers in Atherosclerosis Trials
- The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component.
Related papers
- Antithrombin III. I. Evaluation of an automated antithrombin III method.
- Preoperative antithrombin supplementation in cardiac surgery: a randomized controlled trial.
- Elimination of Intravenously Administered Radiolabelled Antithrombin III and Heparin in Humans
- Influence of Acute Myocardial Infarction and rt-PA Therapy on Circulating Fibrinogen
- PRITHROMBIN TIME DERIVED FIBRINOGEN DETERMINATION ON SYSMEX CA-1500.
- Human fibrinogen heterogeneity. A study of limited fibrinogen degradation.
- Clinical Relevance of Antithrombin III
- Fibrinogen synthesis in rabbits: effects of altered levels of circulating fibrinogen.
- [Studies on antithrombin III. I. Purification and some properties of antithrombin III (ATIII), and the relationship between plasma antithrombin activity and ATIII antigen concentration (author's transl)].
- Antithrombin III transfusion in patients with hepatic cirrhosis